Concepedia

Pulmonary injury after total or partial cardiopulmonary bypass with thromboxane synthesis inhibition

Menachem Friedman, Steven Y. Wang, Frank W. Sellke, A Franklin, Ronald M. Weintraub, Robert G. Johnson

The Annals of Thoracic Surgery · 1995 · 28 citations · 20 references

DOIFull text

Open access

Concepts

References

20

Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor.

Ethan J. Haskel, Sheryl R. Torr, Kathleen C. Day et al. · Circulation · 1991 · 123 citations · Full text

, , +17

Thromboxane and prostacyclin changes during cardiopulmonary bypass with and without pulsatile flow

W. David Watkins, Myron B. Peterson, Daniel Kong et al. · Journal of Thoracic and Cardiovascular Surgery · 1982 · 118 citations

, , +13

Prostaglandin E2, prostacyclin, and thromboxane changes during nonpulsatile cardiopulmonary bypass in humans

Marie-Élisabeth Faymonville, G. Deby‐Dupont, Robert Larbuisson et al. · Journal of Thoracic and Cardiovascular Surgery · 1986 · 103 citations

, , +12

Parameters of pulmonary injury after total or partial cardiopulmonary bypass.

M. Friedman, Sellke Fw, Wang Sy et al. · PubMed · 1994 · 93 citations

, , +15

The influence of selective thromboxane synthetase inhibition with a novel imidazole derivative, UK-38,485, on prostanoid formation in man.

Susan M. Fischer, Michael Struppler, B. Böhlig et al. · Circulation · 1983 · 77 citations

, , +9